Loading company…
THYROSCOPE develops AI medical devices and software for assessing thyroid-related conditions.
Founded in 2020 and based in Ulsan, South Korea, THYROSCOPE develops AI tools for thyroid healthcare. Its Glandy products help providers assess thyroid eye disease, measure eye protrusion, and evaluate thyroid dysfunction risks. They are intended for hospitals, endocrinology clinics, and research institutions, with approvals in the United States and South Korea. In October 2024, the company raised KRW 4 billion in Series A funding from Enlight Ventures, Insight Equity Partners, KDB Infrastructure Investments Asset Management, and Korea Credit Guarantee Fund.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in